Literature DB >> 31168572

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.

U Pastorino, M Silva, S Sestini, F Sabia, M Boeri, A Cantarutti, N Sverzellati, G Sozzi, G Corrao, A Marchianò.   

Abstract

Entities:  

Year:  2019        PMID: 31168572      PMCID: PMC6857602          DOI: 10.1093/annonc/mdz169

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
Ann Oncol 2019; (doi:10.1093/annonc/mdz117) In the original article, the Figure 1 caption contained an erroneous sentence. It has now been corrected to read: ‘Cumulative overall mortality and lung cancer mortality, by arm over 10 years of follow-up.’ The Publisher apologizes for the error.
  21 in total

1.  Cancer Progress and Priorities: Lung Cancer.

Authors:  Matthew B Schabath; Michele L Cote
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10       Impact factor: 4.254

Review 2.  Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocol.

Authors:  Hilary A Robbins; Matthew Callister; Peter Sasieni; Samantha L Quaife; Li C Cheung; Paul Brennan; Hormuzd A Katki; Christine D Berg; David Baldwin; Mattias Johansson
Journal:  Lancet Respir Med       Date:  2019-05-07       Impact factor: 30.700

Review 3.  Lung Cancer Screening with Low-Dose CT: a Meta-Analysis.

Authors:  Richard M Hoffman; Rami P Atallah; Roger D Struble; Robert G Badgett
Journal:  J Gen Intern Med       Date:  2020-06-24       Impact factor: 5.128

4.  Cascaded-Recalibrated Multiple Instance Deep Model for Pathologic-Level Lung Cancer Prediction in CT Images.

Authors:  Qingfeng Wang; Ying Zhou; Jun Huang; Zhiqin Liu; Weidong Zhang; Qiyu Liu; Jie-Zhi Cheng
Journal:  Comput Intell Neurosci       Date:  2022-06-13

5.  Qualitative emphysema and risk of COPD hospitalization in a multicenter CT lung cancer screening cohort study.

Authors:  Lee Gazourian; William B Thedinger; Shawn M Regis; Elizabeth J Pagura; Lori Lyn Price; Melissa Gawlik; Cristina F Stefanescu; Carla Lamb; Kimberly M Rieger-Christ; Harpreet Singh; Marcel Casasola; Alexander R Walker; Arashdeep Rupal; Avignat S Patel; Carolyn E Come; Ava M Sanayei; William P Long; Giulia S Rizzo; Andrea B McKee; George R Washko; Raul San Jose Estepar; Christoph Wald; Brady J McKee; Carey C Thomson; Timothy N Liesching
Journal:  Respir Med       Date:  2020-11-20       Impact factor: 3.415

6.  Effects of low-dose computed tomography on lung cancer screening: a systematic review, meta-analysis, and trial sequential analysis.

Authors:  Kai-Lin Huang; Shih-Yuan Wang; Wan-Chen Lu; Ya-Hui Chang; Jian Su; Yen-Ta Lu
Journal:  BMC Pulm Med       Date:  2019-07-11       Impact factor: 3.317

7.  Evaluation of cardiovascular risk in a lung cancer screening cohort.

Authors:  Mamta Ruparel; Samantha L Quaife; Jennifer L Dickson; Carolyn Horst; Stephen Burke; Magali Taylor; Asia Ahmed; Penny Shaw; May-Jan Soo; Arjun Nair; Anand Devaraj; Emma Louise O'Dowd; Angshu Bhowmik; Neal Navani; Karen Sennett; Stephen W Duffy; David R Baldwin; Reecha Sofat; Riyaz S Patel; Aroon Hingorani; Sam M Janes
Journal:  Thorax       Date:  2019-09-26       Impact factor: 9.102

8.  Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data.

Authors:  Anika Hüsing; Rudolf Kaaks
Journal:  Eur J Epidemiol       Date:  2020-06-27       Impact factor: 8.082

9.  Analysis of lung cancer risk model (PLCOM2012 and LLPv2) performance in a community-based lung cancer screening programme.

Authors:  Mikey B Lebrett; Haval Balata; Matthew Evison; Denis Colligan; Rebecca Duerden; Peter Elton; Melanie Greaves; John Howells; Klaus Irion; Devinda Karunaratne; Judith Lyons; Stuart Mellor; Amanda Myerscough; Tom Newton; Anna Sharman; Elaine Smith; Ben Taylor; Sarah Taylor; Anna Walsham; James Whittaker; Phil V Barber; Janet Tonge; Hilary A Robbins; Richard Booton; Philip A J Crosbie
Journal:  Thorax       Date:  2020-07-06       Impact factor: 9.102

10.  Circulating extracellular vesicles from individuals at high-risk of lung cancer induce pro-tumorigenic conversion of stromal cells through transfer of miR-126 and miR-320.

Authors:  Orazio Fortunato; Gabriella Sozzi; Francesca Pontis; Luca Roz; Mavis Mensah; Miriam Segale; Massimo Moro; Giulia Bertolini; Ilaria Petraroia; Giovanni Centonze; Anna Maria Ferretti; Paola Suatoni; Ugo Pastorino
Journal:  J Exp Clin Cancer Res       Date:  2021-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.